Literature DB >> 23754129

microRNA detection in feces, sputum, pleural effusion and urine: novel tools for cancer screening (Review).

Yu-Feng Xiao1, Xin Yong, Ya-Han Fan, Mu-Han Lü, Shi-Ming Yang, Chang-Jiang Hu.   

Abstract

microRNAs (miRNAs) are short non-coding RNA sequences that play important roles in the regulation of gene expression. They have significant regulatory functions in basic cellular processes, including differentiation, proliferation and apoptosis. miRNAs are differentially expressed in tumors, compared with normal tissues. Importantly, miRNAs are also stable and abundantly present in body fluids and feces. The high reproducibility, sensitivity and specificity of miRNAs in body fluids and feces enable miRNAs to be used as potential molecular markers for cancer screening. An increasingly large number of research studies have reported the role of miRNAs in this field. In the present review, we focused mainly on the application of detecting miRNAs in stool, sputum, pleural effusion and urine, to detect colon, lung and urological cancers, highlighting the role of miRNAs in early diagnosis and prognosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23754129     DOI: 10.3892/or.2013.2525

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  19 in total

1.  miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.

Authors:  Christos K Kontos; Panagiotis Tsiakanikas; Margaritis Avgeris; Iordanis N Papadopoulos; Andreas Scorilas
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

2.  Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis.

Authors:  Ke-Cheng Zhang; Hong-Qing Xi; Jian-Xin Cui; Wei-Song Shen; Ji-Yang Li; Bo Wei; Lin Chen
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

Review 3.  Pattern recognition for predictive, preventive, and personalized medicine in cancer.

Authors:  Tingting Cheng; Xianquan Zhan
Journal:  EPMA J       Date:  2017-03-09       Impact factor: 6.543

Review 4.  MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.

Authors:  Christiane Matuszcak; Joerg Haier; Richard Hummel; Kirsten Lindner
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

5.  Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection.

Authors:  Marc Hirschfeld; Gerta Rücker; Daniela Weiß; Kai Berner; Andrea Ritter; Markus Jäger; Thalia Erbes
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

Review 6.  Genetics and epigenetics of adrenocortical tumors.

Authors:  Antonio M Lerario; Andreas Moraitis; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2013-11-09       Impact factor: 4.102

7.  High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.

Authors:  Stamatia-Maria Rapti; Christos K Kontos; Iordanis N Papadopoulos; Andreas Scorilas
Journal:  Tumour Biol       Date:  2016-04-04

8.  Salivary MicroRNA in Pancreatic Cancer Patients.

Authors:  Marine Humeau; Alix Vignolle-Vidoni; Flavie Sicard; Frédéric Martins; Barbara Bournet; Louis Buscail; Jérôme Torrisani; Pierre Cordelier
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

Review 9.  Noncoding RNA in oncogenesis: a new era of identifying key players.

Authors:  Guorui Deng; Guangchao Sui
Journal:  Int J Mol Sci       Date:  2013-09-05       Impact factor: 5.923

Review 10.  Clinical advances in molecular biomarkers for cancer diagnosis and therapy.

Authors:  Seema Sethi; Shadan Ali; Philip A Philip; Fazlul H Sarkar
Journal:  Int J Mol Sci       Date:  2013-07-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.